Hollis-Eden founder and CEO Richard Hollis was fired 'for cause' by his board, triggering a clause in his contract that strips him of millions of dollars in severance payments.

The company won a favorable ruling in its patent case against Boston Scientific.

Advanced Life Sciences completed antibiotic cethromycin's filing with U.S. regulators and signed an Asian marketing deal with Wyeth.

In an ugly market, it's time to look at the sturdiest large-caps and mid-caps.

Amcol falls on an earnings miss.

Sequoia Capital and Y Combinator have told startups that cutting costs is a priority.

Elon Musk will soon allow Dogecoin to purchase SpaceX merchandise.

The theme park company has opened Guardians of the Galaxy: Cosmic Rewind and not everyone is happy despite the ride getting wonderful reviews.

Aurora is slashing its production capacity as it builds a runway toward positive Ebitda a year from now.